Pacific Alternative Asset Management Company (PAAMCO)’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Pacific Alternative Asset Management Company (PAAMCO)’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-113,821	Closed	-$514K	–	196
2014 Q3	$514K	Buy	113,821 +32,374	+40%	+$174K	0.06%	177
2014 Q2	$550K	Buy	+81,447	New	+$614K	0.07%	160

Other funds holding SRNE

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Baird Milwaukee, Wisconsin $9.78B AUM 11.42% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Pacific Alternative Asset Management Company (PAAMCO)'s SRNE Position: Q4 2014 in Review

Pacific Alternative Asset Management Company (PAAMCO) sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2014, closing a stake of 113,821 shares — an estimated $514K sold.

Pacific Alternative Asset Management Company (PAAMCO) first reported a position in SRNE in Q2 2014 and held it in 2 quarters. The position peaked at $550K in Q2 2014. 38 funds tracked by Wall St. Rank hold SRNE as of Q4 2014.

Pacific Alternative Asset Management Company (PAAMCO) reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2014 after selling out during the quarter.
Pacific Alternative Asset Management Company (PAAMCO) sold 113,821 Sorrento Therapeutics, Inc. shares in Q4 2014, an estimated $514K.
Pacific Alternative Asset Management Company (PAAMCO) first reported a position in Sorrento Therapeutics, Inc. in Q2 2014 and held it in 2 quarters.
Pacific Alternative Asset Management Company (PAAMCO)'s Sorrento Therapeutics, Inc. position peaked at $550K in Q2 2014.
38 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2014.

Based on Pacific Alternative Asset Management Company (PAAMCO)'s 13F filing for Q4 2014, filed 13 Feb 2015.